|
|
|
Insider
Information: |
Nanavaty Maulik |
Relationship: |
|
City: |
Natick |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
177,758 |
|
Indirect Shares
|
11,017 |
|
|
Direct
Value |
$13,232,310 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
188,775 |
|
|
Total
Value |
$13,232,310 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
6.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Boston Scientific Corp |
BSX |
SVP & Pres, Neuromodul... |
2022-02-28 |
177,258 |
|
0 |
Premium* |
|
Rani Therapeutics Holdings, Inc. |
RANI |
|
2023-11-16 |
500 |
2023-11-16 |
11,017 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
13,440 |
268,634 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2020-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,661 |
263,995 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2020-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,713 |
264,884 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2020-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,883 |
265,917 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2020-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,840 |
266,823 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2020-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,629 |
267,539 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2021-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,791 |
238,784 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2021-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,477 |
241,636 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2021-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,661 |
241,057 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2021-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,778 |
242,260 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2021-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,713 |
243,358 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2021-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,883 |
244,648 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2021-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,629 |
245,625 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2022-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,175 |
173,752 |
0 |
- |
|
RANI |
Rani Therapeutics Holding... |
Director |
|
2022-02-03 |
4 |
A |
$0.00 |
$0 |
I/I |
11,017 |
11,017 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2022-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,661 |
173,067 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2022-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,166 |
174,658 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,779 |
175,687 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,714 |
176,785 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,630 |
177,822 |
0 |
- |
|
RANI |
Rani Therapeutics Holding... |
|
|
2023-11-16 |
4 |
B |
$1.98 |
$990 |
D/D |
500 |
500 |
0.01 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2012-10-30 |
4 |
D |
$5.17 |
$8,686 |
D/D |
(1,680) |
65,272 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & President, Neuromodula |
|
2011-10-31 |
4 |
D |
$5.81 |
$9,703 |
D/D |
(1,670) |
48,246 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2012-02-12 |
4 |
D |
$5.93 |
$9,802 |
D/D |
(1,653) |
51,984 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2012-02-16 |
4 |
D |
$5.97 |
$3,875 |
D/D |
(649) |
54,585 |
0 |
- |
|
176 Records found
|
|
Page 3 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|